STAT-Dx Overview
- Year Founded
-
2010
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$191M
STAT-Dx General Information
Description
Manufacturer and developer of a point of care diagnostics device intended to support timely efficient patient care. The company's point of care diagnostics device, DiagCORE, is a portable multi-analyte instrument for molecular and immuno-assay testing for different clinical settings, enabling healthcare providers to consolidate molecular and immunoassay techniques in a single device.
Contact Information
Website
www.stat-dx.comCorporate Office
- Baldiri Reixac 4
- 08028 Barcelona
- Spain
Corporate Office
- Baldiri Reixac 4
- 08028 Barcelona
- Spain
STAT-Dx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 19-Apr-2018 | $191M | Completed | Generating Revenue | ||
| 5. Debt - General | 01-Jun-2017 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series C) | 30-Mar-2016 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series B) | 30-Mar-2016 | Completed | Startup | |||
| 2. Early Stage VC | 26-May-2014 | $11.7M | $14.5M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 15-Jun-2011 | $2.87M | $2.87M | Completed | Startup |
STAT-Dx Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series D | ||||||||
| Series C | 17,735 | $1.113169 | $532.27 | $532.27 | 1x | $532.27 | 19.94% | |
| Series B | 6,400 | $1.113169 | $347.87 | $347.87 | 1x | $347.87 | 7.19% |
STAT-Dx Comparisons
Industry
Financing
Details
STAT-Dx Competitors (14)
One of STAT-Dx’s 14 competitors is Nanomix, a Formerly VC-backed company based in San Leandro, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Nanomix | Formerly VC-backed | San Leandro, CA | ||||
| Randox Laboratories | Corporation | Crumlin, United Kingdom | ||||
| Response Genetics | Corporate Backed or Acquired | Los Angeles, CA | ||||
| Genalyte | Venture Capital-Backed | San Diego, CA | ||||
| Agendia | Venture Capital-Backed | Irvine, CA |
STAT-Dx Patents
STAT-Dx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-12042793-B2 | Dry chemistry container | Active | 18-Jan-2018 | ||
| US-20190217292-A1 | Dry chemistry container | Active | 18-Jan-2018 | ||
| US-20240335834-A1 | Dry chemistry container | Pending | 18-Jan-2018 | ||
| US-10413902-B2 | Apparatus for sample separation and collection | Active | 17-Jul-2015 | ||
| ES-2785927-T3 | Dry chemical container | Active | 17-Jul-2015 | B01L3/502715 |
STAT-Dx Former Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| AXIS Participaciones Empresariales | Corporate Venture Capital | Minority | ||
| Boehringer Ingelheim Venture Fund | Corporate Venture Capital | Minority | ||
| Caixa Capital Risc | Corporate Venture Capital | Minority | ||
| Criteria Bio Ventures | Venture Capital | Minority | ||
| Gilde Healthcare | PE/Buyout | Minority |
STAT-Dx FAQs
-
When was STAT-Dx founded?
STAT-Dx was founded in 2010.
-
Where is STAT-Dx headquartered?
STAT-Dx is headquartered in Barcelona, Spain.
-
What industry is STAT-Dx in?
STAT-Dx’s primary industry is Diagnostic Equipment.
-
Is STAT-Dx a private or public company?
STAT-Dx is a Private company.
-
What is the current valuation of STAT-Dx?
The current valuation of STAT-Dx is .
-
What is STAT-Dx’s current revenue?
The current revenue for STAT-Dx is .
-
How much funding has STAT-Dx raised over time?
STAT-Dx has raised $69.1M.
-
Who are STAT-Dx’s investors?
AXIS Participaciones Empresariales, Boehringer Ingelheim Venture Fund, Caixa Capital Risc, Criteria Bio Ventures, and Gilde Healthcare are 5 of 9 investors who have invested in STAT-Dx.
-
Who are STAT-Dx’s competitors?
Nanomix, Randox Laboratories, Response Genetics, Genalyte, and Agendia are some of the 14 competitors of STAT-Dx.
-
When was STAT-Dx acquired?
STAT-Dx was acquired on 19-Apr-2018.
-
Who acquired STAT-Dx?
STAT-Dx was acquired by Qiagen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process